By proceeding, you agree to our Terms of Use and Privacy Policy.
Buffy Nelson is a specialty market-access specialist with over a decade of experience in the rare and orphan drug space. She currently serve as the director of program management and gene therapy products. Buffy work with multiple rare and ultrarare therapies and she oversee the launch and ongoing success of the gene therapy pipeline products we serve. The gene therapies working with currently assist patients with diagnoses of hemophilia and spinal muscular atrophy, but there are so many more of these products on the horizon, it is truly a unique and amazing time to work in rare disease, getting to be a part of so many transformative and curative therapies coming to market is quite a gift. The rare and orphan disease programs I partner with include Duchenne Muscular Dystrophy, X-Linked Hypophosphatemia, Fabry, Pompe, LC-FAOD, MPS-I, Gaucher, ASMD, CLN2, MPS VI, & Morquio A. With a background in PBM, Medicare, DME, and medical billing, my insurance knowledge assists clients in building programs that best meet the needs of their patients.
Talks About #strategicthinking #problemsolving
Preferred Locations #NorthAmerica